Dr. Turaga on Surgery Versus Immunotherapy in Melanoma

The evolving role of surgery after neoadjuvant immunotherapy in melanomaПодробнее

Meet Surgical Oncologist Kiran Turaga, MD, MPHПодробнее

Adjuvant Surgery in Melanoma: New Approaches to Upfront TherapyПодробнее

Dr. Berman on Evolving Role of Surgery in MelanomaПодробнее

Orthopedic Surgery Insights: Question & Answer with Dr. Ramkinkar JhaПодробнее

Dr. Weber on Discontinuing Immunotherapy in MelanomaПодробнее

Giving Immunotherapy before Surgery in MelanomaПодробнее

Dr. Kiran Turaga on Regional Therapies in MelanomaПодробнее

Dr. Kaufman on T-VEC in MelanomaПодробнее

Dr. Jason Luke Talks About Advances in how Melanoma is DiagnosedПодробнее

Immunotherapy Basics in MelanomaПодробнее

Dr. Daud on Dabrafenib/Trametinib Vs Immunotherapy in MelanomaПодробнее

Melanoma & Immunotherapy: Ask Dr. Michael AtkinsПодробнее

How to treat BRAF Positive Patients with Metastatic Melanoma? | Onc Brothers #2023 #oncology #cancerПодробнее

The Phenomenon of Immunotherapy in MelanomaПодробнее

Dr. Richard Joseph on Necessary Improvements on Immunotherapy in MelanomaПодробнее

The Impacts of Chemotherapy Versus Immunotherapy in MelanomaПодробнее

The personalization of neoadjuvant immunotherapy in stage III melanomaПодробнее

Dr. Andtbacka Discusses the Role of T-VEC in MelanomaПодробнее